Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant

about

High-dose Chemotherapy with Stem Cell Rescue Provided Durable Remission for Classical Hodgkin Lymphoma-type Post-transplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation: A Case Report and Review of the Literature.

P2860

Q39440358-73A0B5C2-104D-42B7-BF9F-77D7EC37BCF7

P2860

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant

Item

http://www.wikidata.org/entity/Q42025417

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Treatment of Recurrent Posttra ...... ous Blood Stem Cell Transplant

@en

Treatment of Recurrent Posttra ...... ous Blood Stem Cell Transplant

@nl

type

Item

label

Treatment of Recurrent Posttra ...... ous Blood Stem Cell Transplant

@en

Treatment of Recurrent Posttra ...... ous Blood Stem Cell Transplant

@nl

prefLabel

Treatment of Recurrent Posttra ...... ous Blood Stem Cell Transplant

@en

Treatment of Recurrent Posttra ...... ous Blood Stem Cell Transplant

@nl

P1476

Treatment of Recurrent Posttra ...... ous Blood Stem Cell Transplant

@en

P2093

Ahmad K Rahal

http://www.w3.org/2001/XMLSchema#string

Bharat Malhotra

http://www.w3.org/2001/XMLSchema#string

Dennis F Moore

http://www.w3.org/2001/XMLSchema#string

Hussam Farhoud

http://www.w3.org/2001/XMLSchema#string

K James Kallail

http://www.w3.org/2001/XMLSchema#string

P2860

Report of the Committee on Hodgkin's Disease Staging Classification

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines.

Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options.

Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies.

Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula.

A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

P304

801082

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/801082

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284722898

http://www.w3.org/2001/XMLSchema#string

P698

26688773

http://www.w3.org/2001/XMLSchema#string

P932

4673324

http://www.w3.org/2001/XMLSchema#string

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant

about

P2860

P2860

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932